Lifestyle Choices Matter
Glixin started way back in late 2011, while I was preparing a Patent Application for Environmental Biotechnology Applications related to a discovery of how to grow autotrophic microbes. I put off the potential applications for medical applications, because I knew it would be a real bear. Do autotrophic microbes have any impact in human health? Autotrophic microbes use CO2 as their carbon source for growth and include methanogens, nitrifying bacteria, anammox, sulfate reducing bacteria (SRB), and more. The methanogens and SRB are found in the human (and other animals) gut, but do they really matter? The answer turns out to be “YES!”. A healthy diet promotes the growth of methanogens, but not the SRB. A diet rich in inorganic sulfur promotes the growth of the SRB, but not the methanogens. So what?
The high levels of SRB may be promoting Blood Oxidative Stress or BLOS, which was a new hypothesis that I published a few years ago. In short, high levels of SRB can generate high levels of hydrogen sulfide (H2S), which diffuses into the local blood stream where it induces the ROS (reactive oxygen species) response in both white blood cells and platelets. This is Blood Oxidative Stress (BLOS). Once induced, BLOS continues 24/7 until the blood cells decay and are replaced by healthy, new blood cells. The continuous generation of ROS causes lots of health problems over the long-term, such as Obesity, Type 2 Diabetes, Atherosclerosis, and a higher risk of Cancers.
Glixin is currently developing a new blood test to accurately measure the BLOS level, so folks can make better lifestyle choices to lower Oxidative Stress. People don’t have to wait for our new blood test to act on this information. I’ve written a Kindle eBook that describes a strategy to evaluate 3 Lifestyle Choices with the use of the MDA Urine Test Kit. Eventually, the MDA Urine Test Kit will be replaced by the BLOS# test. This BLOS# test will enter the market as a Lifestyle Choice test and will transition to a Disease Diagnostic test with successful clinical trials that demonstrate conclusively that lowering BLOS improves human health.
Due to a problem with securing a registered trademark, we have changed the name of the company to Glixin. A pilot study has been initiated with Colorado State University that will demonstrate the bench-top fluorimeter method for measuring BLOS level and compare the BLOS Level for healthy, obese, and Type 2 Diabetes. Glixin will be selling a variety of supplements in 2020 that help folks manage BLOS.
